Determination of minimum inhibitory concentration of third generation cephalosporins and fluoroquinolones on clinical isolates of Pseudomonas aeruginosa
Bapurao Bite, Devendra R. Chaudhari, Kailash Wagh
Abstract
Open-access reader
Bapurao Bite, Devendra R. Chaudhari, Kailash Wagh
Abstract
Open-access reader
Background: Pseudomonas aeruginosa has attracted much attention because of its high incidence of nosocomial infections in recent years. The multidrug resistance of these P. aeruginosa isolates plays an important role in the colonization or infection of chronically hospitalized patients. There is continued search for alternative drugs, such fluoroquinolones, and the third generation cephalosporins. The objective of present study was to test the susceptibility of the clinical isolates of P. aeruginosa to antimicrobials like ciprofloxacin, ofloxacin, ceftazidime, and cefoperazone. To determine their minimum inhibitory concentration (MIC) is in resistant isolates.Methods: The study was conducted in Bacteriology Laboratory, Department of Microbiology, Government Medical College, Miraj. The design of study: in vitro study on 50 clinical isolates of P. aeruginosa.Results: Among the third generation cephalosporins, ceftazidime (64%) exhibited maximum in vitro activity and among the fluoroquinolones ciprofloxacin (54%) exhibited maximum activity. Out of 50 clinical isolates of P. aeruginosa,17 were resistant to all four antimicrobials,22 were susceptible to all four antimicrobials, and 11 clinical isolates of P. aeruginosa showed mixed susceptibility-resistant pattern.Conclusion: MIC values for resistant strains of P. aeruginosa ranged from 0.03 to 32 µg/ml for fluoroquinolones and 0.5-512 µg/ml for third generation cephalosporins.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: Pseudomonas aeruginosa has attracted much attention because of its high incidence of nosocomial infections in recent years. The multidrug resistance of these P. aeruginosa isolates plays an important role in the colonization or infection of chronically hospitalized patients. There is continued search for alternative drugs, such fluoroquinolones, and the third generation cephalosporins. The objective of present study was to test the susceptibility of the clinical isolates of P. aeruginosa to antimicrobials like ciprofloxacin, ofloxacin, ceftazidime, and cefoperazone. To determine their minimum inhibitory concentration (MIC) is in resistant isolates.Methods: The study was conducted in Bacteriology Laboratory, Department of Microbiology, Government Medical College, Miraj. The design of study: in vitro study on 50 clinical isolates of P. aeruginosa.Results: Among the third generation cephalosporins, ceftazidime (64%) exhibited maximum in vitro activity and among the fluoroquinolones ciprofloxacin (54%) exhibited maximum activity. Out of 50 clinical isolates of P. aeruginosa,17 were resistant to all four antimicrobials,22 were susceptible to all four antimicrobials, and 11 clinical isolates of P. aeruginosa showed mixed susceptibility-resistant pattern.Conclusion: MIC values for resistant strains of P. aeruginosa ranged from 0.03 to 32 µg/ml for fluoroquinolones and 0.5-512 µg/ml for third generation cephalosporins.
Key concepts: Ceftazidime, Ciprofloxacin, Pseudomonas aeruginosa, Cephalosporin, Cefoperazone, Microbiology, Minimum inhibitory concentration, Medicine